Green food
RE+ 2024: Ampace to Spotlight UniC Series and Introduce Industry-First Technology to the Americas for the First Time
ANAHEIM,Calif.,Sept. 2,2024-- With the rapid development of technology,innovative energy solutions are becoming the focus of global attention. As a new energy technology innovation company,Ampace comm
Frost Radar™ Positions 14 Top Growth & Innovation Leaders in Global Healthcare Data Interoperability
Frost & Sullivan\'s Benchmarking System Highlights Leading Companies Poised for Growth and Advancing Healthcare Interoperability
Viomi Technology Co., Ltd Announces Completion of Certain IoT@Home Businesses Divestment
GUANGZHOU,China,Aug. 31,2024-- Viomi Technology Co.,Ltd ("Viomi" or the "Company") (NASDAQ: VIOT),a leading technology company for home water solutions in China,today announced tha
OMODA 7 Records 8.0 Acceleration Time during an Extreme Heat Test Performed by OMODA CEO
OMODA 7,the latest compact crossover SUV of OMODA and JAECOO,is coming to the Philippines in the near future.
Silkland Launches First 16K VESA-Certified USB C to DisplayPort 2.1 Cable on Amazon
NEW YORK,Sept. 3,2024-- Silkland,a tech brand specializing in cables and accessories,has released the first-ever 16K VESA-certified USB C to DisplayPort 2.1 cable to support the future of visual displ
Committed to Deliver Marvelous Experience to Indonesians, Indosat Ooredoo Hutchison Complete the World's First Large PS Core Network Consolidation & Transformation
JAKARTA,Indonesia,Aug. 28,2024--Indosat Ooredoo Hutchison (Indosat or IOH),the most preferred digital telco of Indonesia,in cooperation with global ICT solution provider Huawei,has finalized a large c
DPC Dash Ltd Announces 2024 Interim Financial Results
Revenues increased to RMB2.04 billion,representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million,from an adjusted net loss of RMB17.4 million in the same period of 2023
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization
Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines
SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow
Babilou Family Singapore Empowers Educators with Global Best Practices Through Inter-Country Learning Journey Initiative
The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.